Side effects Dosage information During pregnancy FDA approval history Drug class: miscellaneous coagulation modifiers En español Patient resources Roctavian drug information Professional resources Valoctocogene Roxaparvovec monograph Related treatment guides Hemophilia A Medical...
(BioMarin), including without limitation, statements about: the FDA planned inspection of the valoctocogene roxaparvovec manufacturing facility, the FDA plans for an advisory committee meeting, and the possibility of regulatory approval. These forward-loo...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that an individual in Germany with severe hemophilia A was treated with ROCTAVIAN® (valoctocogene roxaparvovec-rvox), marking the first time that the gene therapy has been ...